Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the introduction of the Applied Biosystems Advanced Gene Expression Service Provider Program, a new program for service providers who are interested in accessing Applied Biosystems comprehensive solution for gene expression analysis, including the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan® Gene Expression Assays for target validation. The program includes a bundled product option for the entire gene expression workflow application and technical and promotional support that is expected to enhance service providers?business offerings.
The program, intended to assist service providers in genetic analysis using interpretation tools and content to advance scientific research while helping them achieve necessary return on investment, was announced today in advance of this weekend’s annual World Microarray Congress in Vancouver, Canada.
The Applied Biosystems Expression Array System forms the technical platform for the program and can be optionally bundled with companion products that comprise Applied Biosystems?whole solution for gene expression analysis, including microarrays for human, mouse, and rat, TaqMan® Gene Expression Assays, and Real-Time PCR Systems.
Additional data analysis and promotional support is included with the Applied Biosystems Advanced Gene Expression Service Provider Program. Participants will have access to the Celera Discovery System?Online Platform and Panther?Protein Classification System, a Service Provider web link on the Applied Biosystems Web site, and on-site seminars to educate customers to help provide increased business opportunities.
“Under the program, organizations offering gene expression analysis services can now offer their clients a complete gene expression analysis system backed with technical and promotional support package from the leader in gene expression technologiesPage: 1 2 Related biology news :1
. Applied scientists create wrinkled skin on polymers2
. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research3
. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer4
. Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease5
. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible6
. Iron Deficiency Sparks Dramatic Changes In Gene Expression7
. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses8
. Gene Expression in the Aging Brain